Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathways.

MLA

Li, Xinyi, et al. “Irisin Alleviates Pulmonary Epithelial Barrier Dysfunction in Sepsis-Induced Acute Lung Injury via Activation of AMPK/SIRT1 Pathways.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 118, Oct. 2019, p. 109363. EBSCOhost, https://doi.org/10.1016/j.biopha.2019.109363.

APA

Li, X., Jamal, M., Guo, P., Jin, Z., Zheng, F., Song, X., Zhan, J., & Wu, H. (2019). Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathways. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 118, 109363. https://doi.org/10.1016/j.biopha.2019.109363

Chicago

Li, Xinyi, Muhammad Jamal, Peipei Guo, Zhao Jin, Feng Zheng, Xuemin Song, Jia Zhan, and Huisheng Wu. 2019. “Irisin Alleviates Pulmonary Epithelial Barrier Dysfunction in Sepsis-Induced Acute Lung Injury via Activation of AMPK/SIRT1 Pathways.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 118 (October): 109363. doi:10.1016/j.biopha.2019.109363.